Tharimmune, Inc. (THAR)
NASDAQ: THAR · Real-Time Price · USD
3.090
+0.190 (6.55%)
At close: Oct 24, 2025, 4:00 PM EDT
3.080
-0.010 (-0.32%)
After-hours: Oct 24, 2025, 5:47 PM EDT
Tharimmune Market Cap
Tharimmune has a market cap or net worth of $18.24 million as of October 24, 2025. Its market cap has increased by 682.20% in one year.
Market Cap
18.24M
Enterprise Value
16.30M
1-Year Change
682.20%
Ranking
Category
Stock Price
$3.09
Market Cap Chart
Since the IPO on January 12, 2022, Tharimmune's market cap has decreased from $41.18M to $18.24M, a decrease of -55.71%. That is a compound annual growth rate of -19.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2025 | 17.12M | 336.10% |
| Dec 31, 2024 | 3.93M | 205.38% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -89.09% |
| Jan 12, 2022 | 41.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 739.77B |
| Johnson & Johnson | 461.73B |
| AbbVie | 405.07B |
| UnitedHealth Group | 327.13B |
| AstraZeneca | 258.15B |
| Novartis AG | 254.23B |
| Novo Nordisk | 237.27B |
| Abbott Laboratories | 219.56B |